News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
178 Results
Type
Article (19)
Press Release (159)
Section
Business (49)
Deals (13)
Drug Development (33)
FDA (8)
Job Trends (2)
News (80)
Policy (5)
Tag
Alliances (15)
Antibody-drug conjugate (ADC) (1)
Approvals (8)
Best Places to Work (2)
Cancer (9)
Cell therapy (1)
Clinical research (29)
Collaboration (1)
COVID-19 (5)
Data (5)
Earnings (15)
Events (42)
FDA (10)
Funding (1)
Government (1)
Healthcare (3)
Infectious disease (5)
IPO (6)
Legal (2)
Mergers & acquisitions (6)
NextGen: Class of 2026 (2)
People (15)
Phase 1 (25)
Phase 2 (21)
Phase 3 (8)
Pipeline (3)
Preclinical (2)
Real estate (1)
Regulatory (5)
Research institute (1)
Startups (5)
Date
Last 30 days (1)
Last 365 days (22)
2026 (1)
2025 (25)
2024 (14)
2023 (13)
2022 (33)
2021 (41)
2020 (8)
2019 (7)
2018 (4)
2016 (2)
2015 (3)
2014 (4)
2013 (3)
2012 (1)
2011 (1)
2010 (1)
Location
Asia (113)
California (31)
China (18)
Europe (17)
New Jersey (1)
Northern California (1)
Pennsylvania (1)
Southern California (30)
United States (31)
178 Results for "adagene".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adagene Provides Business Update and 2026 Objectives
January 26, 2026
·
5 min read
Press Releases
Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126)
December 16, 2025
·
5 min read
Press Releases
Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China
September 8, 2025
·
3 min read
Press Releases
Adagene to Participate in Two Investor Conferences in September 2025
August 27, 2025
·
2 min read
Press Releases
Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
November 14, 2025
·
4 min read
Press Releases
Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates
August 13, 2025
·
15 min read
Press Releases
Adagene Expands SAFEbody® Collaboration and License Agreement with Exelixis to Develop Third Novel Masked Antibody-Drug Conjugate
September 17, 2025
·
3 min read
Press Releases
Adagene and ConjugateBio Partner to Develop Novel Antibody Drug Conjugate
July 9, 2025
·
3 min read
Press Releases
Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor
September 4, 2025
·
4 min read
Press Releases
Adagene announces up to $25 million strategic investment from Sanofi
July 2, 2025
·
5 min read
1 of 18
Next
